Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

Learn more› By Elissa Sanci Elissa Sanci is a senior writer who has reported on label makers, tumblers, and more. She once dumped glitter in her car to test handheld vacuums. A label maker has ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...